Avantor Inc is a global supplier of ultra-pure materials and integrated solutions for the life sciences and advanced technology sectors. The company supports a wide range of industries by providing high-quality products, including chemicals, reagents, and consumables, as well as laboratory services and customized solutions. Avantor's extensive portfolio is designed to enhance research and development, manufacturing processes, and quality control, helping customers accelerate innovation and improve outcomes across various applications, from pharmaceuticals to biotechnology and diagnostics. Its commitment to sustainability and operational excellence drives the company's mission to enhance scientific discovery and guide advancements in the scientific community. Read More
Over the past six months, Avantor’s shares (currently trading at $11.46) have posted a disappointing 17.5% loss, well below the S&P 500’s 9.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately
as healthcare stocks were up 11.5% over the past six months, almost identical to the S&P 500.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avantor (AVTR) To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
LOS ANGELES, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 29, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”).
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Avantor To Contact Him Directly To Discuss Their Options
LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LOS ANGELES, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) between March 5, 2024 and October 28, 2025, inclusive.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Avantor To Contact Him Directly To Discuss Their Options
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Avantor (NYSE:AVTR) and its peers.
LOS ANGELES, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprouts Farmers Market, Inc. (NASDAQ: SFM) and Avantor, Inc. (NYSE:AVTR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) between March 5, 2024 and October 28, 2025, inclusive.
LOS ANGELES, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprouts Farmers Market, Inc. (NASDAQ: SFM) and Avantor, Inc. (NYSE:AVTR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Shares of life sciences company Avantor (NYSE:AVTR)
jumped 4.2% in the afternoon session after a company director, Sanjeev K Mehra, disclosed the purchase of 350,000 shares for a total of $3.8 million. This significant insider buy, executed at prices between $10.98 and $11.21, signaled strong confidence from leadership, especially as the stock traded near its 52-week low. The purchase followed a period of negative sentiment for the company. Avantor had previously released disappointing third-quarter financial results, which included a 4.7% decline in organic revenue and a net loss of $712 million, largely due to a non-cash goodwill impairment charge. These results, which were attributed to competitive pressures, led to analyst downgrades from firms including Raymond James and JPMorgan.
